FindTrial
Sign In

To test Platelet-Rich Plasma (PRP) Use in Surgery for Treating Anal Fistula

Platelet-Rich Plasma (PRP) Augmentation with Fistulotomy and Primary Sphincter Reconstruction (FPR) in the Management of Fistulain-Ano: A Double-Blind Randomized Controlled Trial - PRISMA

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097562
Enrollment
98
Registered
2025-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures Health Condition 2: K928- Other specified diseases of the digestive system

Interventions

Intervention1: Platelet-Rich Plasma (PRP) Augmentation: a treatment that combines a surgical procedure called a fistulotomy with the injection of PRP into the wound area to promote healing. Control In

Sponsors

All India Institute of Medical Sciences Bhubaneswar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient more than 18 years planned for FPR

Exclusion criteria

Exclusion criteria: Patients with contraindication to FPR, refusal to participate in the study

Design outcomes

Primary

MeasureTime frame
Time to Complete Healing: Defined as the number of days from surgery to the complete closure of the fistula wound with no discharge or infection.Timepoint: 30 days—

Secondary

MeasureTime frame
Recurrence Rate:Timepoint: one-year;HealingTimepoint: 3 months—

Countries

India

Contacts

Public ContactDr Pankaj Kumar

All India Institute of Medical Sciences,Bhubaneswar

drpkushwaha@gmail.com9711090814

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026